- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Leukemia, B-Cell
Total 1475 results
-
Kami Maddocks, MDNovartisCompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone... and other conditionsUnited States
-
C. Babis AndreadisGlaxoSmithKline; University of California, San FranciscoCompletedDiffuse Large Cell Lymphoma Relapsed/RefractoryUnited States
-
RenJi HospitalThe First Affiliated Hospital with Nanjing Medical University; Shanghai Zhongshan... and other collaboratorsCompletedPulmonary Arterial HypertensionChina
-
ADC Therapeutics S.A.Withdrawn
-
Genentech, Inc.CompletedLymphocytic Leukemia, Chronic, Diffuse Large B-Cell LymphomaUnited States, Australia
-
Shanghai Zhangjiang Biotechnology Limited CompanySuspendedB-cell Chronic Lymphocytic LeukemiaChina
-
Memorial Sloan Kettering Cancer CenterColumbia University; Genentech, Inc.Completed
-
Institut BergoniéNational Cancer Institute, FranceCompleted
-
Adicet Bio, IncEnrolling by invitationLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell LymphomaUnited States
-
Fondazione Italiana Linfomi ONLUSJanssen Pharmaceutica; Janssen-Cilag Ltd.; Centro di Riferimento per l'Epidemiologia...CompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-cell Lymphoma RefractoryItaly
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced NeutropeniaGermany, Italy, Spain
-
National Cancer Institute (NCI)CompletedLeukemia, Lymphoblastic, Acute | ALL, ChildhoodUnited States
-
Novartis PharmaceuticalsCompletedSoft Tissue Sarcoma | Small Cell Lung Cancer | Gastric Adenocarcinoma | Diffuse Large B Cell Lymphoma | Esophageal Adenocarcinoma | Ovarian Adenocarcinoma | Castration Resistant Prostate Adenocarcinoma | Advanced Well-differentiated Neuroendocrine TumorsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade... and other conditionsUnited States
-
Triphase Research and Development III Corp.CompletedLymphoma | Lymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, Marginal ZoneCanada, United States
-
University College, LondonPfizer; Cancer Research UKCompletedDiffuse Large B Cell LymphomaUnited Kingdom
-
Constellation PharmaceuticalsCompleted
-
Eden BioCell Ltd.National Taiwan University HospitalTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Acute Lymphoblastic Leukemia | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryTaiwan
-
ImmunityBio, Inc.WithdrawnLymphoma | Lymphoma, B-Cell | Diffuse Large B Cell Lymphoma | Large-cell LymphomaUnited States
-
TG Therapeutics, Inc.TerminatedMantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Small Lymphocytic Lymphoma | B-cell LymphomasUnited States
-
Shanghai Henlius BiotechCompleted
-
Shanghai Henlius BiotechCompleted
-
Shanghai Henlius BiotechCompleted
-
University of Colorado, DenverNational Cancer Institute (NCI)WithdrawnDiffuse Large B Cell Lymphoma
-
Curis, Inc.CompletedRelapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc AlterationsUnited States, Spain
-
Ruijin HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
Hospital for Special Surgery, New YorkCompletedTotal Knee ArthroplastyUnited States
-
Weill Medical College of Cornell UniversityFDA Office of Orphan Products Development; The Leukemia and Lymphoma Society; Karyopharm Therapeutics IncCompletedDiffuse Large B-Cell LymphomaUnited States
-
Cancer Research UKAstraZenecaCompletedAdult Solid Tumor | Burkitt Lymphoma | Diffuse Large B Cell LymphomaUnited Kingdom
-
Shanghai Zhongshan HospitalWuxi People's Hospital; Shanghai Minhang Central HospitalCompletedTranslational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell LymphomaLymphoma, Large B-Cell, Diffuse | Gene Expression ProfilingChina
-
Alexion PharmaceuticalsPortola PharmaceuticalsCompletedFollicular Lymphoma (FL/Indolent NHL) | Aggressive NHL (a NHL) | Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) | T-cell Lymphoma (PTCL and CTCL) | B-cell Non Hodgkin Lymphoma (NHL)United States
-
Swiss Group for Clinical Cancer ResearchTerminatedNon-Hodgkin LymphomaSwitzerland
-
Kosin University Gospel HospitalCompletedDiffuse Large B Cell LymphomaKorea, Republic of
-
ADC Therapeutics S.A.WithdrawnDiffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedLeukemia | Chronic | Lymphocytic | B-CellUnited States
-
Incyte CorporationCompletedLymphomaUnited States, Spain, Korea, Republic of, Belgium, Australia, Czechia, Poland, Canada, France, Italy, United Kingdom
-
Hebei Yanda Ludaopei HospitalChina Immunotech (Beijing) Biotechnology Co., Ltd.Completed
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B Cell LymphomaItaly
-
SCRI Development Innovations, LLCGenentech, Inc.; AmgenCompletedNon-Hodgkins LymphomaUnited States
-
Novartis PharmaceuticalsWithdrawnDiffuse Large B-Cell Lymphoma (DLBCL)
-
Triumvira Immunologics, Inc.Withdrawn
-
Northwestern UniversityNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Active, not recruitingDiffuse Large B-Cell Lymphoma | Plasmablastic Lymphoma | B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma | Adult Burkitt Lymphoma | MYC Gene MutationUnited States
-
Washington University School of MedicineCelgene; Seagen Inc.CompletedLymphoma, Large B-Cell, DiffuseUnited States
-
National Cancer Institute (NCI)TerminatedLymphoma, B-Cell | Chronic Lymphocytic Leukemia | Lymphoma, Non-hodgkins | B-Cell Chronic Lymphocytic LeukemiaUnited States
-
Beijing Tsinghua Chang Gung HospitalChina Immunotech Pharmaceuticals Co.Ltd.Suspended
-
Pharmacyclics LLC.Janssen Research & Development, LLC; Celgene CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom, Belgium, Germany
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruiting
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.CompletedRelapse | Lymphomas Non-Hodgkin's B-CellChina
-
Hoffmann-La RocheCompletedDiffuse Large B-cell Lymphoma | High-Grade B-cell LymphomaUnited States, Spain, Australia, Denmark